Moreover, IGF-2 application reduced protein aggregation in models of HD [49] and transduction with IGF-2-expressing vector caused a significant reduction in extracellular Aβ42 level measured in the culture medium from Tg2576 cultures [20]. This evidence concerns the gene IGF2 and Huntington disease.